Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV-TK Gene Therapy in Liver Transplantation for HCC
NCT03313596Phase 3Unknown
- Sponsor
- Huazhong University of Science and Technology
- Start
- Mar 2013
- Primary completion
- Dec 2019
- Modality
- Gene Editing, Gene Silencing, Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 3 trial of aglatimagene besadenovec in hepatocellular carcinoma (HCC), sponsored by Huazhong University of Science and Technology. Status: unknown.
02
Drugs
aglatimagene besadenovec
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03313596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03313596.